Key facts
- Timothy G. Youngquist 2020 Irrevocable Trust filed SCHEDULE 13G/A for Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS).
- Disclosed ownership: 8.3%.
- Date of event: 05 Feb 2026.
Timothy G. Youngquist 2020 Irrevocable Trust - 05 Feb 2026 SCHEDULE 13G/A Report for Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS)
- Filing Manager
- Timothy G. Youngquist 2020 Irrevocable Trust
- Reporting Manager
- Timothy G. Youngquist 2020 Irrevocable Trust
- Symbol
- CHRS
- Shares outstanding
- 154,721,181 shares
- Disclosed Ownership
- 12,790,800 shares
- Ownership
- 8.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 11 May 2026, 09:21:09 UTC
- Date of event
- 05 Feb 2026
- Next filing
- 15 May 2026
- SEC
- View on sec.gov
Key filing fact
Timothy G. Youngquist 2020 Irrevocable Trust disclosed 8.3% ownership in Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS) on 05 Feb 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 11 May 2026, 09:21.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Timothy G. Youngquist 2020 Irrevocable Trust | 8.3% | 12,790,800 | 12,790,800 | 0 | Nolan Rheam | Manager |
CIK / CUSIP context first